Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring



Rating:

Share or cite this content

Citations should be made in the following way:
Diana Bilton (Huntingdon, United Kingdom), Diana Bilton, Noreen Caine, Rebecca Cosgriff, Stephen Nyangoma, Siobhan Carr. Use of national disease registries in the conduct of long-term post-authorisation drug safety studies (LTSSs). Eur Respir J 2016; 48: Suppl. 60, 4868

Member's Comments

No comment yet.

Related content which might interest you: Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases) Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Predicting mortality in idiopathic pulmonary fibrosis. Which parameters should be used to determine eligibility for treatment? Analysis of a UK prospective cohort Source: International Congress 2016 – The best is yet to come in terms of lung function Year: 2016 Interim analysis of the EXCITING-ILD registry Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Pirfenidone post-authorization safety registry (PASSPORT) update Source: International Congress 2015 – Treatment of IPF Year: 2015 Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development Source: Eur Respir J 2007; 29: 582-586 Year: 2007 CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 Respiratory effects of cannabis smoking: A literature review Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Pirfenidone post-authorization safety registry (PASSPORT) – Interim analysis of IPF treatment Source: International Congress 2014 – Clinical trials in IPF Year: 2014 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting Source: International Congress 2014 – ILDs 6 Year: 2014 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Polish Spirometry Day 2013 as a way to increase public awareness concerning the causes, course and consequences of chronic respiratory diseases Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs Source: Eur Respir Rev 2009; 18: 18-23 Year: 2009 Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Clinical use of interstitial lung disease guidelines Source: Eur Respir Mon; 2009: 46: 386–395 Year: 2009 Recruiting to telehealth has a role during discharge planning in COPD: A feasibility and acceptability study Source: Annual Congress 2013 –The latest insights in chronic care Year: 2013 The quality of evidence-based clinical practice guidelines for chronic respiratory diseases could be improved: An observational study Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy Year: 2016 Translating research into practice: how are guidelines implemented? Source: Eur Respir J 2003; 21: 23S-29S Year: 2003 Collating data from major European population studies – The CADSET (Chronic airway disease early stratification) clinical research collaboration Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020 European COPD Audit: design, organisation of work and methodology Source: Eur Respir J 2013; 41: 270-276 Year: 2013